Ambeed.cn

首页 / / / 热休克蛋白 / Pimitespib

Pimitespib {[allProObj[0].p_purity_real_show]}

货号:A423911 同义名: Tas-116

TAS-116 is a potent and selective HSP90α/β inhibitor with Kis of 34.7 nM, 21.3 nM, respectively.

Pimitespib 化学结构 CAS号:1260533-36-5
Pimitespib 化学结构
CAS号:1260533-36-5
Pimitespib 3D分子结构
CAS号:1260533-36-5
Pimitespib 化学结构 CAS号:1260533-36-5
Pimitespib 3D分子结构 CAS号:1260533-36-5
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

Pimitespib 纯度/质量文件 产品仅供科研

货号:A423911 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nat. Biomed. Eng., 2024, 8, 1412-1424. Ambeed. [ A538667 , A631746 ]
JMC, 2024. Ambeed. [ A833302 , A475501 , A341986 , A356070 ]
BMC Cancer, 2024, 24(1): 1415. Ambeed. [ A809692 , A209020 ]
J. Am. Soc. Mass Spectrom., 2024, 35(12): 3192-3202. Ambeed. [ A166127 , A902473 , A753371 , A961334 , A292945 , A230770 , A300620 , A1114580 , A1159765 , A206238 ]
PloS One, 2024, 19(11): e0308060. Ambeed. [ A302917 ]
更多 >

Pimitespib 生物活性

描述 TAS-116 is a potent and selective HSP90α/β inhibitor with Kis of 34.7 nM, 21.3 nM, respectively.

Pimitespib 临床研究

NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT02965885 Advanced Solid Tumors Phase 1 Recruiting March 2020 United States, Ohio ... 展开 >> Gabrail Cancer Center Recruiting Canton, Ohio, United States, 44718 University Hospitals Case Medical Center Recruiting Cleveland, Ohio, United States, 44106 United States, South Carolina Greenville Health System, Institute for Translational Oncology Research Recruiting Greenville, South Carolina, United States, 29605 United States, Virginia US Oncology - Virginia Cancer Specialists, P.C. Recruiting Fairfax, Virginia, United States, 86885 Italy Policlinico S.Orsola-Malpighi, U.O. Oncologia Medica Recruiting Bologna, Italy, 40138 Contact: Stefania Salvagni    0039 0512142204    stefania.salvagni@aosp.bo.it    Azienda Ospedaliero-Universitaria Policlinico-Vittorio Emanuele Oncologia Medica Recruiting Catania, Italy, 95123 Contact: Soto Parra    0039 0953782426    hsotoparra@policlinico.unict.it    Contact       hsotoparra@yahoo.it    Istituto Europeo di Oncologia , Sviluppo di Nuovi Farmaci per Terapie Innovative Recruiting Milano, Italy, 20141 Contact: Giuseppe Curigliano    0039 0257489439    giuseppe.curigliano@ieo.it    Regina Elena National Cancer Institute Not yet recruiting Roma, Italy, 00144 Contact: Francesco Cognetti    0039 0652666919    francesco.cognetti@ifo.gov.it    United Kingdom Northern Centre for Cancer Care Recruiting Newcastle Upon Tyne, England, United Kingdom Contact: Ruth Plummer    +44 (0) 191 208 4414    Ruth.Plummer@newcastle.ac.uk    Division of Cancer Studies, Kings College London Recruiting London, United Kingdom, SE19 9RT Sarah Cannon Research Institute UK Recruiting London, United Kingdom, W1G 6AD The Christie NHS Foundation Trust Institute of Cancer Sciences, University of Manchester Recruiting Manchester, United Kingdom, M20 4BX Royal Marsden Recruiting Sutton, United Kingdom, SM2 5PTT 收起 <<

Pimitespib 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.20mL

0.44mL

0.22mL

11.00mL

2.20mL

1.10mL

22.00mL

4.40mL

2.20mL

Pimitespib 技术信息

CAS号1260533-36-5
分子式C25H26N8O
分子量 454.527
别名 Tas-116
运输蓝冰
存储条件

液体 -20°C:3-6个月-80°C:12个月

粉末 Sealed in dry,Store in freezer, under -20°C

溶解度

DMSO: 120 mg/mL(264.01 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方
Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。